After the United States Food and Drug Administration gave its nod, the US administration has started the vaccination program. As part of the first phase, more than a million US nationals were vaccinated.
Two US-based pharma giants Pfizer and Moderna who got the nod from the FDA have dispensed the vaccine doses for the vaccine drive. However, the vaccine doses were not given to the children.
The reason for this is, the vaccines developed by the pharma giants are not advised for the children as the volunteers on whom the vaccines were tested are above the age group of 18.
Teenager volunteers were not picked by the pharma companies during the clinical trials of the vaccine. So there is no substantial evidence to prove how it works on the children.
It is also said that compared to adults, the positive percentage of the Covid-19 is very less in children. The positive rate of Covid-19 in kids is said to be only half of the rate in adults.
It has been widely reported that the US-based biotechnology company Moderna is gearing up to start clinical trials of the vaccine on children between the age group of 12-17. The pediatric clinical trials are expected to start very soon.
Two US-based pharma giants Pfizer and Moderna who got the nod from the FDA have dispensed the vaccine doses for the vaccine drive. However, the vaccine doses were not given to the children.
The reason for this is, the vaccines developed by the pharma giants are not advised for the children as the volunteers on whom the vaccines were tested are above the age group of 18.
Teenager volunteers were not picked by the pharma companies during the clinical trials of the vaccine. So there is no substantial evidence to prove how it works on the children.
It is also said that compared to adults, the positive percentage of the Covid-19 is very less in children. The positive rate of Covid-19 in kids is said to be only half of the rate in adults.
It has been widely reported that the US-based biotechnology company Moderna is gearing up to start clinical trials of the vaccine on children between the age group of 12-17. The pediatric clinical trials are expected to start very soon.